NOVARTIS AG (NVSEF)
Clinical trial NCT05870579 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 22 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05870579 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 22 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07424222 updates: 1. start date: 2026-06-01 → 2026-07-15 2. completion date: 2029-01-01 → 2029-02-01 3. primary completion date: 2028-06-01 → 2028-07-01
Clinical trial NCT03796884 updates: 1. enrollment: 230 → 150 participants 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07660029: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT04018053 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2025-09-25
Clinical trial NCT06197672 updates: 1. completion date: 2042-12-31 → 2042-12-01 2. primary completion date: 2027-12-31 → 2027-12-01
Clinical trial NCT05084053 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2024-03-05 → 2025-10-28
Clinical trial NCT06755359 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-01 → 2026-03-01
Clinical trial NCT07655479 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-04-23
Clinical trial NCT05991349: enrollment: 180 → 36 participants.